A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

التفاصيل البيبلوغرافية
العنوان: A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
المؤلفون: Wei Zhou, Lee D. Cranmer, Igor Puzanov, Caroline Robert, Paolo A. Ascierto, Christian U. Blank, Antoni Ribas, April K.S. Salama, Omid Hamid, Steven J. O'Day, Adil Daud, F. Stephen Hodi, Rene Gonzalez, Jacob Schachter, Reinhard Dummer, Peter Soonmo Kang, Dirk Schadendorf, Joy Lis, Nicole Li, Anna C. Pavlick, Scot Ebbinghaus
المصدر: Journal of Translational Medicine
بيانات النشر: Springer Nature
مصطلحات موضوعية: Medicine(all), Chemotherapy, medicine.medical_specialty, Temozolomide, business.industry, Biochemistry, Genetics and Molecular Biology(all), medicine.medical_treatment, Melanoma, Ipilimumab, General Medicine, Pembrolizumab, medicine.disease, Bioinformatics, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Refractory, Internal medicine, medicine, Oral Presentation, Therapy duration, In patient, business, medicine.drug
الوصف: 2 and 10 mg/kg Q3W, respectively, over control (P
اللغة: English
تدمد: 1479-5876
DOI: 10.1186/1479-5876-13-s1-o5
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b244a2465aeff5cd7d5e9ef6b7ed366cTest
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....b244a2465aeff5cd7d5e9ef6b7ed366c
قاعدة البيانات: OpenAIRE
الوصف
تدمد:14795876
DOI:10.1186/1479-5876-13-s1-o5